clinical trials

NIAID launches clinical trial network for preventive drugs, vaccines against Covid-19
NIAID launches clinical trial network for preventive drugs, vaccines against Covid-19
MedCity News
NIAID
clinical trials
COVID-19 Prevention Trials Network
vaccines
Flag link:
A flawed Covid-19 study gets the White House’s attention — and the FDA may pay the price
A flawed Covid-19 study gets the White House’s attention — and the FDA may pay the price
Stat
FDA
hydroxychloroquine
COVID-19
White House
clinical trials
Flag link:
Gilead Testing Inhaled Form Of Remdesivir That Could Be Used To Treat Covid-19 Outside Hospital
Gilead Testing Inhaled Form Of Remdesivir That Could Be Used To Treat Covid-19 Outside Hospital
Forbes
Gilead Sciences
remdesivir
COVID-19
pandemic
clinical trials
Flag link:
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint
Could Amgen test Enbrel or other anti-TNF drugs against COVID-19? CEO Bradway drops a hint
Fierce Pharma
Amgen
clinical trials
COVID-19
anti-TNF
Enbrel
Bob Bradway
Pharma CEOs
Flag link:
Moderna Completes Enrollment for Phase II Vaccine Trial
Moderna Completes Enrollment for Phase II Vaccine Trial
TheStreet.com
Moderna Therapeutics
clinical trials
vaccines
mRNA-1273
COVID-19
Flag link:
Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy
Corvus begins phase 1 Covid-19 clinical trial with novel immunotherapy
Pharmaceutical Business Review
Corvus Pharmaceuticals
clinical trials
immunotherapy
COVID-19
CPI-006
Flag link:
Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients
Sanofi, Regeneron shut down Kevzara trial in COVID-19 after finding no benefit for ventilated patients
Fierce Pharma
Sanofi
Regeneron
Kevzara
clinical trials
COVID-19
Flag link:
Vor Biopharma Snags $110 Million to Advance AML Treatment into the Clinic
Vor Biopharma Snags $110 Million to Advance AML Treatment into the Clinic
BioSpace
Vor Biopharma
funding
stem cells
clinical trials
oncology
AML
Flag link:
Moderna spars with U.S. scientists over COVID-19 vaccine trials
Moderna spars with U.S. scientists over COVID-19 vaccine trials
Reuters
Moderna Therapeutics
COVID-19
vaccines
clinical trials
Flag link:
Sunovion’s SEP-4199 fails to meet primary endpoint in SEP380-201 trial
Sunovion’s SEP-4199 fails to meet primary endpoint in SEP380-201 trial
Pharmaceutical Business Review
Sunovion
clinical trials
SEP-4199
bipolar disorder
Flag link:
Second PhIII study for Idorsia's sleep drug returns positive results, but also raises new questions
Second PhIII study for Idorsia's sleep drug returns positive results, but also raises new questions
Endpoints
Idorsia
daridorexant
insomnia
clinical trials
Flag link:
Obseva shows why red flags are worth heeding
Obseva shows why red flags are worth heeding
EP Vantage
ObsEva
uterine fibroids
clinical trials
linzagolix
Flag link:
Bellus hit with a setback as its PhII chronic cough drug flops on all 4 doses -- shares cremated on Wall Street
Bellus hit with a setback as its PhII chronic cough drug flops on all 4 doses -- shares cremated on Wall Street
Endpoints
Bellus Health
BLU-5937
clinical trials
chronic cough
Flag link:
Regeneron Starts Late-Stage Trials of Coronavirus Cocktail
Regeneron Starts Late-Stage Trials of Coronavirus Cocktail
TheStreet.com
Regeneron
clinical trials
REGN-COV2
COVID-19
Flag link:
Data show panic and disorganization dominate the study of Covid-19 drugs
Data show panic and disorganization dominate the study of Covid-19 drugs
Stat
drug development
clinical trials
pandemic
COVID-19
Flag link:
Regeneron's Arthritis Drug Fails COVID-19 Trial
Regeneron's Arthritis Drug Fails COVID-19 Trial
Motley Fool
Regeneron
Kevazara
COVID-19
pandemic
clinical trials
Flag link:
Analysts hail Akero's midphase NASH data as best in class
Analysts hail Akero's midphase NASH data as best in class
Fierce Biotech
Akero Therapeutics
clinical trials
NASH
efruxifermin
Flag link:
Daiichi Sankyo expands DS-1062 study to include patients with triple negative breast cancer
Daiichi Sankyo expands DS-1062 study to include patients with triple negative breast cancer
Pharmaceutical Business Review
Daiichi Sankyo
antibody-drug conjugate
triple negative breast cancer
DS-1062
clinical trials
Flag link:
Coronavirus Shot From Pfizer, BioNtech Shows Promise in Early Test
Coronavirus Shot From Pfizer, BioNtech Shows Promise in Early Test
Yahoo/Bloomberg
clinical trials
vaccines
COVID-19
pandemic
Pfizer
BioNTech
Flag link:
Experimental HIV drug seems effective at a twice-a-year dose, study finds
Experimental HIV drug seems effective at a twice-a-year dose, study finds
Stat
HIV
Gilead Sciences
lenacapavir
clinical trials
Flag link:

Pages